Biomarkers of disease progression in the spinal cord in MS

Dr Tal Koren

Brain and Mind Centre, The University of Sydney, NSW

July 2026

Specialisation: Neurobiology

focus area: Better treatments

funding type: Scholarship

project type: Investigator Led Research

Summary

Multiple sclerosis (MS) can damage the spinal cord. This damage is strongly linked to physical disability and disease progression. However, current magnetic resonance imaging (MRI) scans are not sensitive enough to reliably detect small changes in the spinal cord over time. This makes it harder for doctors to accurately monitor disease activity and progression. Dr Koren says people with MS often express frustration that their MS is worsening but there is no clear evidence of this on their MRI scan. This project aims to improve how spinal cord damage is detected and measured in people with MS.

Dr Tal Koren will analyse existing MRI scans from people with MS who have had spinal cord imaging over several years. He will measure areas of damage and changes in spinal cord size over time. These scans will be used to develop and train an artificial intelligence (AI) model that can automatically detect and track spinal cord damage across multiple timepoints.

He will then recruit adults with MS who are already undergoing routine MRI scans. In addition to the standard scans, participants will receive a newer, high-resolution 3D MRI scan of the spinal cord. He will compare the standard scans with the 3D scans to determine whether the new method can detect more lesions or more subtle changes, and to test the AI model. He will also examine how these imaging findings relate to clinical disability.

Overall, this study aims to develop more accurate and automated ways for tracking spinal cord damage in MS, which could improve how disease progression is monitored over time. More sensitive tools also help decide whether treatment is working effectively or should be revisited.

lead investigator

co-investigators

total funding

$120,000

start year

2027

duration

2.5 years

STATUS

Current project

Stages of the research process

Fundamental laboratory Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline

10+ years

Translational Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline

5+ years

Clinical Studies and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline

3+ years

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Biomarkers of disease progression in the spinal cord in MS